Previous Article | Next Article ![]()
Antimicrob. Agents Chemother., 10 1997, 2127-2131, Vol 41, No. 10
AH Lin, RW Murray, TJ Vidmar and KR Marotti
The oxazolidinones are a novel class of antibiotics that act by inhibiting
protein synthesis. It as been reported that the drug exerts its primary
activity on the initiation phase of translation. In order to study the
possibility of direct interaction between the drug and the ribosome, we
have developed a binding assay using 14C-labelled eperezolid (PNU-100592;
formerly U-100592). Eperezolid binds specifically to the 50S ribosomal
subunit of Escherichia coli. The specific binding of eperezolid is dose
dependent and is proportional to the ribosome concentrations. Scatchard
analysis of the binding data reveals that the dissociation constant (Kd) is
about 20 microM. The binding of eperezolid to the ribosome is competitively
inhibited by chloramphenicol and lincomycin. However, unlike
chloramphenicol and lincomycin, eperezolid does not inhibit the puromycin
reaction, indicating that the oxazolidinones have no effect on peptidyl
transferase. In addition, whereas lincomycin and, to some extent,
chloramphenicol inhibit translation termination, eperezolid has no effect.
Therefore, we conclude that the oxazolidinones inhibit protein synthesis by
binding to the 50S ribosomal subunit at a site close to the site(s) to
which chloramphenicol and lincomycin bind but that the oxazolidinones are
mechanistically distinct from these two antibiotics.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin
Molecular Biology Research, Pharmacia & Upjohn, Kalamazoo, Michigan 49007, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»